The Executive Committee is comprised of the officers who are selected by the Board, and the Immediate Past President. It conducts the day-to-day operations on behalf of the Board during the intervals between the Board meetings.
Joris Vandeputte, DVM (Belgium): President
Jean Hugues Trouvin Pharm.D. (France) : Vice President
Anthony Lubiniecki, PhD (USA): Treasurer
Daniel Gaudry, DVM (France/USA): Secretary
"Ex officio" members
An ex officio member is a member of a body (a board, committee, council, etc.) who is part of it by virtue of holding another office. The “ex offcio” members of the Executive Committee are expected to participate when an agenda item relevant to their Committee is discussed. The Chairs of the Committees and the Immediate Past president are “ex officio” members:
Takao Hayakawa, PhD (Japan): Chair of the Cell & Gene Therapy Committee
Rick Hill, DVM (USA) : Chair of the Communication Committee
Carmen Jungbäck, DVM (Germany): Chair Veterinary Biologicals Committee.
Anthony Mire Sluis, PhD (USA): Chair Biotherapeutics Committee
Pieter Neels, MD (Belgium): Chair Human Vaccine Communication Committee.
John Petricciani, MD (USA): Immediate Past President
Please find all the biosketches in the Documents section